Funding Details
- Awarder
- SOSV
- Date Award
- May 13, 2024
- Vertical
- Computational Bio
- Funding URL
- View Funding Page
Company Info
- Founding Year
- None
- Traction
- None
- Organizations Involved
- None
- Founders
- Edward Painter, Sridhar Vempati, Matthew Welsch
- Company Description
- A2A Pharmaceuticals has designed new drug candidates for cancers like Leukemia and other life-threatening diseases. A2A’s technology platform optimizes the efficacy of such options while minimizing toxicity much faster and more precisely than competitors. We build and evaluate small molecule libraries that consist of thousands to millions of members until we obtain candidates with optimal properties and matches.
- Market
- Human Health
- Location
-
United States
- Coinvestors
- None
Links